Buy NovaBay Pharmaceuticals Stock | NBY Stock Price & Latest News | Public.com
NBY

NovaBay Pharmaceuticals

$0.00 (0.00%)Today
    Small Market Cap
    View NovaBay Pharmaceuticals (NBY) stock trends here

    About NBY

    NovaBay Pharmaceuticals, Inc. engages in development of products for eye care. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA. The full company name is NovaBay Ph...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.03
    -0.05
    -0.08
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.04

    Actual EPS
    Q2 2021

    Stats

    Market Cap$34,32M
    Volume94,91k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$1.94
    1 Year Low$0.52
    Open$0.81
    High$0.81
    Low$0.76

    Buy any stock with any amount of money.

    Download the App
    Download the app